Efeito agudo do salbutamol no sistema cardiovascular durante o exercício físico em pacientes com asma moderada ou grave: estudo aleatorizado, duplo-cego e cruzado
DOI:
https://doi.org/10.1590/1809-2950/17007725022018Palavras-chave:
Asma, Albuterol, Exercício, Frequência Cardíaca, Pressão ArterialResumo
Salbutamol é um β2-agonista de curta duração frequentemente utilizado em pacientes com asma para prevenir os sintomas durante ou após exercício físico. Alterações hemodinâmicas em repouso estão bem descritas. Contudo são escassos os dados sobre os efeitos na frequência cardíaca (FC) e pressão arterial (PA) durante o exercício e na fase de recuperação em pacientes com asma moderada ou grave. Foi realizado um estudo aleatorizado, duplo-cego e cruzado, em que foram inclusos 15 indivíduos com asma moderada e grave, com média de idade de 46,4±9,3 anos. Os pacientes realizaram um teste de esforço máximo em dois dias não consecutivos, com administração de 400mcg de salbutamol ou 4 “puffs” de placebo. Durante todo o protocolo foi monitorada a FC, a PA, a percepção de esforço e o pico de fluxo expiratório (PFE). Após o uso do salbutamol, o valor do PFE aumentou em média de 28,0±47,7L/m, permanecendo maior nos tempos de 5, 10 e 15 minutos de recuperação passiva em relação ao placebo (p<0,05). As variáveis FC, PA e percepção de esforço foram semelhantes entre as intervenções em todas as fases do protocolo (p>;0,05). Esses resultados sugerem que o uso de salbutamol é seguro, e que a FC não necessita de ser ajustada para prescrever a intensidade do exercício após a administração de salbutamol em indivíduos com asma moderada ou grave.Downloads
Referências
Bateman ED, Hurd SS, Barnes PJ, Bousquet J, Drazen JM,
FitzGerald JM, et al. Global strategy for asthma management
and prevention: GINA executive summary. Eur Respir J.
;31(1):143-78. doi: 10.1183/09031936.00138707
Goldney RD, Ruffin R, Fisher LJ, Wilson DH. Asthma
symptoms associated with depression and lower quality
of life: a population survey. Med J Aust [Internet]. 2003
[cited 2018 May 30];178(9):437-41. Available from: https://
www.mja.com.au/system/files/issues/178_09_050503/
gol10589_fm.pdf
Salpeter SR, Ormiston TM, Salpeter EE. Cardiovascular
effects of beta-agonists in patients with asthma and COPD:
a meta-analysis. Chest. 2004;125(6):2309-21. doi: 10.1378/
chest.125.6.2309
Mendes FA, Almeida FM, Cukier A, Stelmach R, Jacob-Filho
W, Martins MA, et al. Effects of aerobic training on airway
inflammation in asthmatic patients. Med Sci Sports Exerc.
;43(2):197-203. doi: 10.1249/MSS.0b013e3181ed0ea3
Mendes FA, Goncalves RC, Nunes MP, Saraiva-Romanholo
BM, Cukier A, Stelmach R, et al. Effects of aerobic training
on psychosocial morbidity and symptoms in patients with
asthma: a randomized clinical trial. Chest. 2010;138(2):331-7.
doi: 10.1378/chest.09-2389
Franca-Pinto A, Mendes FA, Carvalho-Pinto RM,
Agondi RC, Cukier A, Stelmach R, et al. Aerobic training
decreases bronchial hyperresponsiveness and systemic
inflammation in patients with moderate or severe asthma: a randomised controlled trial. Thorax. 2015;70(8):732-9. doi:
1136/thoraxjnl-2014-206070
Bonini M, Palange P. Exercise-induced bronchoconstriction:
new evidence in pathogenesis, diagnosis and
treatment. Asthma Res Pratice. 2015;1(2):1-6. doi:
1186/s40733-015-0004-4
Carson KV, Chandratilleke MG, Picot J, Brinn MP, Esterman AJ,
Smith BJ. Physical training for asthma. Cochrane Database
Syst Rev. 2013;(9). doi: 10.1002/14651858.CD001116.pub4
Cekici L, Valipour A, Kohansal R, Burghuber OC. Shortterm effects of inhaled salbutamol on autonomic
cardiovascular control in healthy subjects: a placebocontrolled study. Br J Clin Pharmacol. 2009;67(4):394-402.
doi: 10.1111/j.1365-2125.2009.03377.x
Molis MA, Molis WE. Exercise-induced bronchospasm. Sports
Health. 2010;2(4):311-7. doi: 10.1177/1941738110373735
Leite M, Ponte EV, Petroni J, D’Oliveira Junior A, Pizzichini
E, Cruz AA. Evaluation of the asthma control questionnaire
validated for use in Brazil. J Bras Pneumol. 2008;34(10):756-63.
doi: 10.1590/S1806-37132008001000002
Cardoso MN, Chong Neto HJ, Rabelo LM, Riedi CA, Rosario NA.
Utility of Asthma Control Questionnaire 7 in the assessment
of asthma control. J Bras Pneumol. 2014;40(2):171-4. doi:
1590/S1806-37132014000200011
Dockhorn R, Vanden Burgt JA, Ekholm BP, Donnell D, Cullen
MT. Clinical equivalence of a novel non-chlorofluorocarboncontaining salbutamol sulfate metered-dose inhaler and
a conventional chlorofluorocarbon inhaler in patients
with asthma. J Allergy Clin Immunol. 1995;96(1):50-6. doi:
1016/S0091-6749(95)70032-3
Joffe D, Berend N. Assessment and management
of dyspnoea. Respirology. 1997;2(1):33-43. doi:
1111/j.1440-1843.1997.tb00052.x
Feitosa MS, Melo JR, Medeiros WM, Cucato GG, Stelmach R,
Cukier A, et al. Effect of salbutamol on the cardiovascular
response in healthy subjects at rest, during physical
exercise, and in recovery phase: a randomized, double-blind,
crossover study. Motriz: Rev Educ Fís. 2017;23(3):1-7. doi:
1590/s1980-6574201700030012
Tanaka H, Monahan KD, Seals DR. Age-predicted maximal
heart rate revisited. J Am Coll Cardiol. 2001;37(1):153-6. doi:
1016/S0735-1097(00)01054-8
Swain DP, Leutholtz BC. Heart rate reserve is equivalent
to %VO2 reserve, not to %VO2max. Med Sci Sports Exerc.
;29(3):410-4.
Capuchinho-Junior GA, Dias RM, Carvalho SRS. One hour
effects of salbutamol and formoterol on blood pressure, heart
rate and oxygen saturation in asthmatics. Rev Port Pneumol.
;14(3):353-61. doi: 10.1016/S0873-2159(15)30243-9
Eryonucu B, Uzun K, Guler N, Bilge M. Comparison of the
acute effects of salbutamol and terbutaline on heart rate
variability in adult asthmatic patients. Eur Respir J [Internet].
[cited 2018 May 30];17(5):863-7. Available from: http://
erj.ersjournals.com/content/17/5/863
Qing F, Rahman SU, Hayes MJ, Rhodes CG, Ind PW, Jones
T, et al. Effect of long-term beta2-agonist dosing on human
cardiac beta-adrenoceptor expression in vivo: comparison
with changes in lung and mononuclear leukocyte betareceptors. J Nucl Cardiol. 1997;4(6):532-8.
Freeman W, Packe GE, Cayton RM. Effect of nebulised
salbutamol on maximal exercise performance in men with
mild asthma. Thorax. 1989;44(11):942-7.
Nici L, ZuWallack R. Pulmonary rehabilitation for patients
with chronic airways obstruction. J Allergy Clin Immunol: In
practice. 2015;3(4):512-8. doi: 10.1016/j.jaip.2015.05.023
Zainudin BM, Biddiscombe M, Tolfree SE, Short M, Spiro SG.
Comparison of bronchodilator responses and deposition
patterns of salbutamol inhaled from a pressurised metered
dose inhaler, as a dry powder, and as a nebulised solution.
Thorax. 1990;45(6):469-73.
Cole CR, Blackstone EH, Pashkow FJ, Snader CE, Lauer
MS. Heart-rate recovery immediately after exercise as a
predictor of mortality. N Engl J Med. 1999;341(18):1351-7. doi:
1056/NEJM199910283411804
Shetler K, Marcus R, Froelicher VF, Vora S, Kalisetti D, Prakash
M, et al. Heart rate recovery: validation and methodologic
issues. J Am Coll Cardiol. 2001;38(7):1980-7. doi:
1016/S0735-1097(01)01652-7
Peres P, Carvalho AC, Perez AB, Medeiros WM. Abnormal
heart rate recovery and deficient chronotropic response
after submaximal exercise in young Marfan syndrome
patients. Cardiology in the young. 2016;26(7):1274-81. doi:
1017/S1047951115002322
Medeiros WM, Luca FA, Figueredo Junior AR, Mendes FA,
Gun C. Heart rate recovery improvement in patients following
acute myocardial infarction: exercise training, beta-blocker
therapy or both. Clin Physiol Funct Imaging. 2018;38(3):351-9.
doi: 10.1111/cpf.12420
Schmidt A, Diamant B, Bundgaard A, Madsen PL. Ergogenic
effect of inhaled beta 2-agonists in asthmatics. Int J Sports
Med. 1988;9(5):338-40. doi: 10.1055/s-2007-1025036
Ienna TM, McKenzie DC. The asthmatic athlete: metabolic
and ventilatory responses to exercise with and without preexercise medication. Int J Sports Med. 1997;18(2):142-8. doi:
1055/s-2007-972610
Dekker FW, Schrier AC, Sterk PJ, Dijkman JH. Validity of peak
expiratory flow measurement in assessing reversibility of
airflow obstruction. Thorax. 1992;47(3):162-6
Downloads
Publicado
Edição
Seção
Licença
Copyright (c) 2018 Fisioterapia e Pesquisa
Este trabalho está licenciado sob uma licença Creative Commons Attribution-ShareAlike 4.0 International License.
